Lung diseases like tuberculosis and cystic fibrosis can be difficult to treat. In part, that's because the two-dimensional models researchers use to study the diseases don't accurately reflect the ...
Bronchoscopy-based lower airway sequencing showed higher resistome abundance and diversity in COPD, bronchiectasis, and ...
The lung disease bronchiectasis plays out as a vicious cycle. Infection leads to inflammation followed by the impaired ability to clear the excess mucus coughed up from the lungs. These problems lead ...
The FDA has approved Insmed’s brensocatib, the first treatment for non-cystic fibrosis bronchiectasis, a chronic and progressive lung disease affecting about 500,000 people in the U.S. The drug was ...
Oct. 9, 2025, marks the first-ever Lung Transplant Awareness Day. This initiative is dedicated to uniting the lung disease patient community, raising awareness of this lifesaving medical procedure and ...
An international study has found that patients with chronic lung conditions like COPD, bronchiectasis, and severe asthma have significantly higher levels and diversity of antibiotic resistance genes ...
Lung cancer poses a potential smoke screen for today’s pulmonologists. Overall, incidence rates continue to decline in the US as other cancers are on the rise, yet a growing number of patients are ...
Abenacianine, a fluorescent imaging agent, received FDA fast track status for enhancing tumor visualization during lung cancer surgery, showing safety and efficacy in phase 2 trials. Alecensa ...
In the 2000s, when the AIDS pandemic hit South Africa, we were seeing a lot of children dying from HIV. That was just before ...
Biomarker testing has shifted expectations in advanced lung cancer, with expanding actionable alterations and an “explosion” of recent approvals translating into longer survival and improved quality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results